| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |